A detailed history of Valeo Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 37,516 shares of NVO stock, worth $5.36 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
37,516
Previous 37,146 1.0%
Holding current value
$5.36 Million
Previous $4.77 Million 1.01%
% of portfolio
0.14%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $37,780 - $50,290
370 Added 1.0%
37,516 $4.82 Million
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $1.14 Million - $1.52 Million
11,177 Added 43.04%
37,146 $4.77 Million
Q4 2023

Jan 29, 2024

BUY
$87.78 - $105.45 $231,036 - $277,544
2,632 Added 11.28%
25,969 $2.69 Million
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $1.34 Million - $2.95 Million
14,764 Added 172.22%
23,337 $2.12 Million
Q2 2023

Jul 14, 2023

SELL
$155.98 - $172.65 $3,119 - $3,453
-20 Reduced 0.23%
8,573 $1.39 Million
Q1 2023

Apr 17, 2023

BUY
$132.34 - $159.14 $429,707 - $516,727
3,247 Added 60.74%
8,593 $1.37 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $252,580 - $333,317
2,463 Added 85.43%
5,346 $723,000
Q3 2022

Oct 31, 2022

SELL
$95.28 - $116.93 $44,591 - $54,723
-468 Reduced 13.97%
2,883 $287,000
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $230,947 - $272,488
-2,237 Reduced 40.03%
3,351 $373,000
Q1 2022

Apr 28, 2022

BUY
$93.1 - $112.54 $172,979 - $209,099
1,858 Added 49.81%
5,588 $621,000
Q4 2021

Jan 07, 2022

BUY
$95.88 - $117.08 $11,505 - $14,049
120 Added 3.32%
3,730 $418,000
Q3 2021

Nov 02, 2021

BUY
$84.42 - $106.62 $304,756 - $384,898
3,610 New
3,610 $347,000
Q2 2021

Jul 22, 2021

SELL
$67.66 - $84.76 $885,195 - $1.11 Million
-13,083 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$67.06 - $75.82 $8,449 - $9,553
126 Added 0.97%
13,083 $882,000
Q4 2020

Feb 11, 2021

BUY
$63.89 - $73.8 $703,556 - $812,685
11,012 Added 566.17%
12,957 $905,000
Q3 2020

Oct 28, 2020

SELL
$63.69 - $70.22 $5,859 - $6,460
-92 Reduced 4.52%
1,945 $135,000
Q2 2020

Jul 20, 2020

BUY
$58.54 - $67.94 $72,179 - $83,770
1,233 Added 153.36%
2,037 $133,000
Q1 2020

Apr 13, 2020

BUY
$49.46 - $64.78 $6,083 - $7,967
123 Added 18.06%
804 $48,000
Q4 2019

Jan 24, 2020

BUY
$49.86 - $58.26 $3,639 - $4,252
73 Added 12.01%
681 $39,000
Q3 2019

Oct 15, 2019

SELL
$47.54 - $53.43 $998 - $1,122
-21 Reduced 3.34%
608 $31,000
Q2 2019

Jul 10, 2019

BUY
$46.79 - $52.47 $24,611 - $27,599
526 Added 510.68%
629 $32,000
Q1 2019

Apr 12, 2019

SELL
$46.36 - $52.63 $463 - $526
-10 Reduced 8.85%
103 $5,000
Q4 2018

Jan 30, 2019

SELL
$41.54 - $47.25 $20,894 - $23,766
-503 Reduced 81.66%
113 $5,000
Q3 2018

Nov 01, 2018

BUY
$46.76 - $51.24 $12,251 - $13,424
262 Added 74.01%
616 $27,000
Q1 2018

Apr 12, 2018

SELL
$48.49 - $58.14 $630 - $755
-13 Reduced 3.54%
354 $17,000
Q4 2017

Feb 09, 2018

BUY
$47.53 - $53.73 $12,547 - $14,184
264 Added 256.31%
367 $20,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $4,238 - $5,069
103
103 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.